Fusion-positive cases showed significantly better survival than fusion-negative cases, suggesting that MECT1-MAML2 represents a specific prognostic molecular marker in MEC.    ///    "Fusion-positive cases showed significantly better survival than fusion-negative cases, suggesting that MECT1-MAML2 represents a specific prognostic molecular marker in MEC. "    ///    "Although the incidence of this fusion in MEC varies, it is generally accepted that more than 50?% of this entity manifest the MECT1-MAML2. "